Literature DB >> 17262765

Risk of venous thromboembolism in patients undergoing cancer surgery and options for thromboprophylaxis.

David Bergqvist1.   

Abstract

Patients with cancer have an increased risk of developing venous thromboembolism (VTE) due to a hypercoagulable state associated with malignancy. This risk is further complicated in patients undergoing cancer-related surgery due to immobility, other cancer treatments, and biologic changes associated with surgery. Despite this relatively high risk of VTE, many patients are not prescribed adequate prophylaxis in the pre- or post-operative periods. This article reviews available measures for thromboprophylaxis in light of current guidelines. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17262765     DOI： 10.1002/jso.20625

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  12 in total

Review 1.  Optimizing the management of elderly colorectal surgery patients.

Authors:  Kok-Yang Tan; Fumio Konishi; Lawrence Tan; Wui-Kin Chin; Hean-Yee Ong; Phyllis Tan
Journal:  Surg Today       Date:  2010-11-03       Impact factor: 2.549

2.  Changing practice: implementation of a venous thromboembolism prophylaxis protocol at an academic medical center.

Authors:  Christopher J Pannucci; Reda M Jaber; Justin M Zumsteg; Vlad Golgotiu; Lisa M Spratke; Edwin G Wilkins
Journal:  Plast Reconstr Surg       Date:  2011-11       Impact factor: 4.730

3.  Visualization of in vivo thromboprophylactic and thrombolytic efficacy of enoxaparin in laser-induced vascular endothelial injury model using multiphoton microscopy.

Authors:  Koji Tanaka; Yuhki Koike; Kohei Matsushita; Masato Okigami; Yuji Toiyama; Mikio Kawamura; Susumu Saigusa; Yoshinaga Okugawa; Yasuhiro Inoue; Keiichi Uchida; Toshimitsu Araki; Yasuhiko Mohri; Akira Mizoguchi; Masato Kusunoki
Journal:  Am J Transl Res       Date:  2015-01-15       Impact factor: 4.060

4.  Diagnosis of VTE postdischarge for major abdominal and pelvic oncologic surgery: implications for a change in practice.

Authors:  Hamad Alsubaie; Carly Leggett; Pascal Lambert; Jason Park; David Hochman; Debrah Wirtzfeld; Andrew McKay
Journal:  Can J Surg       Date:  2015-10       Impact factor: 2.089

5.  Role of factor xa inhibitors in cancer-associated thrombosis: any new data?

Authors:  Ali Zalpour; Michael H Kroll; Vahid Afshar-Kharghan; Syed Wamique Yusuf; Carmen Escalante
Journal:  Adv Hematol       Date:  2011-10-15

6.  Influence of propofol intravenous anesthesia on hemorheology, haemodynamics and immune function of colorectal carcinoma patients undergoing radical resection.

Authors:  Jianmin Yu; Mingfen Han; Jun Geng
Journal:  Pak J Med Sci       Date:  2019       Impact factor: 1.088

7.  Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study.

Authors:  Siân Sweetland; Jane Green; Bette Liu; Amy Berrington de González; Marianne Canonico; Gillian Reeves; Valerie Beral
Journal:  BMJ       Date:  2009-12-03

8.  Development and validation of a risk calculator for post-discharge venous thromboembolism following hepatectomy for malignancy.

Authors:  Cary Jo R Schlick; Ryan J Ellis; Ryan P Merkow; Anthony D Yang; David J Bentrem
Journal:  HPB (Oxford)       Date:  2020-09-26       Impact factor: 3.647

9.  Effect of ovarian tumor characteristics on venous thromboembolic risk.

Authors:  Arvind Bakhru
Journal:  J Gynecol Oncol       Date:  2013-01-08       Impact factor: 4.401

Review 10.  Management of venous thromboembolism in patients with cancer: role of dalteparin.

Authors:  Lori-Ann Linkins
Journal:  Vasc Health Risk Manag       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.